X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
quinoxalines - pharmacology (5632) 5632
animals (5345) 5345
rats (3077) 3077
male (3001) 3001
neurosciences (1956) 1956
humans (1727) 1727
pharmacology & pharmacy (1550) 1550
in vitro techniques (1346) 1346
excitatory amino acid antagonists - pharmacology (1318) 1318
female (1223) 1223
mice (1171) 1171
dose-response relationship, drug (1106) 1106
rats, sprague-dawley (1076) 1076
brimonidine tartrate (930) 930
oxadiazoles - pharmacology (827) 827
rats, wistar (794) 794
enzyme inhibitors - pharmacology (762) 762
neurons - drug effects (683) 683
2-amino-5-phosphonovalerate - pharmacology (630) 630
quinoxalines - chemistry (624) 624
cells, cultured (595) 595
chemistry, medicinal (594) 594
6-cyano-7-nitroquinoxaline-2,3-dione (588) 588
glutamate (588) 588
biochemistry & molecular biology (571) 571
electric stimulation (562) 562
neurons (535) 535
physiology (531) 531
quinoxalines - chemical synthesis (527) 527
neurons - physiology (517) 517
adrenergic alpha-agonists - pharmacology (495) 495
time factors (494) 494
quinoxalines - therapeutic use (493) 493
nitric oxide (491) 491
rat (483) 483
receptors, n-methyl-d-aspartate - antagonists & inhibitors (478) 478
quinoxalines - administration & dosage (468) 468
receptors, ampa - antagonists & inhibitors (453) 453
structure-activity relationship (443) 443
dizocilpine maleate - pharmacology (420) 420
synapses - physiology (392) 392
receptors, n-methyl-d-aspartate - physiology (370) 370
guanylate cyclase - antagonists & inhibitors (365) 365
varenicline (362) 362
brain (354) 354
inhibition (347) 347
synaptic transmission - drug effects (347) 347
activation (342) 342
hippocampus - drug effects (333) 333
adult (332) 332
calcium - metabolism (325) 325
membrane potentials - drug effects (318) 318
synapses - drug effects (318) 318
animals, newborn (317) 317
quinoxalines - metabolism (314) 314
n-methylaspartate - pharmacology (313) 313
in-vitro (310) 310
patch-clamp techniques (308) 308
expression (306) 306
imidazoles - pharmacology (304) 304
nitric oxide - metabolism (303) 303
molecular structure (301) 301
hippocampus (296) 296
rats, inbred strains (290) 290
receptors (285) 285
middle aged (283) 283
kinetics (282) 282
mice, inbred c57bl (282) 282
quinoxalines (282) 282
drug interactions (281) 281
tetrodotoxin - pharmacology (280) 280
hippocampus - physiology (278) 278
quinoxaline (274) 274
synaptic transmission - physiology (272) 272
research (270) 270
electrophysiology (269) 269
piperazines - pharmacology (268) 268
bicuculline - pharmacology (265) 265
kainic acid - pharmacology (265) 265
analysis (264) 264
nitric-oxide (261) 261
cyclic gmp - metabolism (260) 260
excitatory postsynaptic potentials - drug effects (260) 260
action potentials - drug effects (257) 257
nervous system (255) 255
ng-nitroarginine methyl ester - pharmacology (254) 254
neurons - metabolism (245) 245
antineoplastic agents - pharmacology (242) 242
long-term potentiation (240) 240
adrenergic alpha-antagonists - pharmacology (237) 237
evoked potentials - drug effects (236) 236
cells (233) 233
excitatory amino acid agonists - pharmacology (231) 231
apoptosis (229) 229
research article (229) 229
nmda (228) 228
disease models, animal (227) 227
cell line, tumor (226) 226
receptors, n-methyl-d-aspartate - drug effects (225) 225
pharmacology (223) 223
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6941) 6941
Japanese (118) 118
Russian (63) 63
German (54) 54
French (22) 22
Chinese (20) 20
Italian (10) 10
Czech (6) 6
Polish (5) 5
Romanian (4) 4
Slovak (4) 4
Croatian (3) 3
Spanish (3) 3
Dutch (2) 2
Finnish (1) 1
Portuguese (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 01/2010, Volume 30, Issue 2, pp. 545 - 555
Marijuana is a widely used drug that impairs memory through interaction between its psychoactive constituent, Delta-9-tetrahydrocannabinol (Delta(9)-THC), and... 
CA1 Region, Hippocampal - cytology | Receptor, Adenosine A1 - physiology | Neurons - cytology | Xanthines - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Patch-Clamp Techniques - methods | Receptor, Cannabinoid, CB1 - physiology | Excitatory Postsynaptic Potentials - physiology | Quinoxalines - pharmacology | Neural Inhibition - physiology | Receptor, Cannabinoid, CB1 - agonists | Piperidines - pharmacology | Caffeine - pharmacology | Dronabinol - pharmacology | Electric Stimulation - methods | Pyrazoles - pharmacology | Presynaptic Terminals - drug effects | Mice, Inbred C57BL | Morpholines - pharmacology | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Biophysics | Calcium Channel Blockers - pharmacology | GABA Antagonists - pharmacology | Mice, Knockout | Naphthalenes - pharmacology | Methoxyhydroxyphenylglycol - analogs & derivatives | Methoxyhydroxyphenylglycol - pharmacology | Animals | Analysis of Variance | Phosphinic Acids - pharmacology | Benzoxazines - pharmacology | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacology | Adenosine - metabolism | Picrotoxin - pharmacology | Presynaptic Terminals - metabolism | Glutamic Acid - metabolism | Mice | Receptor, Cannabinoid, CB1 - deficiency | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | In Vitro Techniques | Propanolamines - pharmacology | Neural Inhibition - drug effects
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2009, Volume 29, Issue 2, pp. 393 - 401
Glucocorticoids exert an opposing rapid regulation of glutamate and GABA synaptic inputs to hypothalamic magnocellular neurons via the activation of... 
GABA | Magnocellular neuron | Endocannabinoid | Glucocorticoid | Nitric oxide | SUPRAOPTIC NUCLEUS | endocannabinoid | glucocorticoid | nitric oxide | ACTIVATION | magnocellular neuron | NITRIC-OXIDE SYNTHASE | NEUROSCIENCES | MEMBRANE ESTROGEN-RECEPTORS | ENDOCANNABINOID RELEASE | PARAVENTRICULAR NUCLEUS | G(alpha) | ADRENALECTOMIZED RATS | NEURONS | VASOPRESSIN | OXYTOCIN | G(beta)gamma | Cannabinoid Receptor Modulators - metabolism | Synaptic Transmission - physiology | gamma-Aminobutyric Acid - metabolism | GTP-Binding Proteins - antagonists & inhibitors | Male | Penicillamine - analogs & derivatives | Patch-Clamp Techniques - methods | Quinoxalines - pharmacology | Dexamethasone - pharmacology | Piperidines - pharmacology | Dronabinol - analogs & derivatives | Neurons - physiology | Nitric Oxide Donors - pharmacology | Dronabinol - pharmacology | Neurons - drug effects | Electric Stimulation - methods | Pyrans - pharmacology | Guanosine Diphosphate - pharmacology | Pyrazoles - pharmacology | Cyclic AMP-Dependent Protein Kinases - metabolism | Synapses - drug effects | Synapses - physiology | Penicillamine - pharmacology | Valine - analogs & derivatives | Enzyme Inhibitors - pharmacology | Rats | Excitatory Amino Acid Antagonists - pharmacology | Thionucleotides - pharmacology | Rats, Sprague-Dawley | Animals | Guanosine Diphosphate - analogs & derivatives | Hypothalamus - cytology | Signal Transduction - drug effects | Arginine - pharmacology | Cannabinoid Receptor Modulators - antagonists & inhibitors | Glucocorticoids - pharmacology | Glutamic Acid - metabolism | Valine - pharmacology | In Vitro Techniques | Nitric Oxide - metabolism | GTP-Binding Proteins - metabolism | Gβγ
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 05/2007, Volume 34, Issue 5, pp. 387 - 392
SUMMARY • Astragaloside IV is a component from the widely used traditional Chinese herb Astragalus membranaceus and its effect on rat aortic ring contraction... 
endothelium | nitric oxide | aortic rings | vessel contraction and relaxation | astragaloside IV | Astragaloside IV | Nitric oxide | Vessel contraction and relaxation | Aortic rings | Endothelium | SMOOTH-MUSCLE | PHYSIOLOGY | CONTRACTION | TONE | L-ARGININE | PHARMACOLOGY & PHARMACY | CHANNELS | Triterpenes - pharmacology | Muscle, Smooth, Vascular - metabolism | Calcium - metabolism | Nitric Oxide Synthase - antagonists & inhibitors | Male | Saponins - chemistry | Endothelium, Vascular - physiology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Intracellular Fluid - drug effects | Triterpenes - chemistry | Phenylephrine - pharmacology | Oxadiazoles - pharmacology | Aorta, Thoracic - physiology | Potassium Chloride - pharmacology | Molecular Structure | Aorta, Thoracic - drug effects | Cyclic GMP - biosynthesis | Intracellular Fluid - metabolism | Muscle, Smooth, Vascular - drug effects | NG-Nitroarginine Methyl Ester - pharmacology | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Acetylcholine - pharmacology | Rats | Vasodilator Agents - isolation & purification | Muscle, Smooth, Vascular - cytology | Rats, Sprague-Dawley | Indomethacin - pharmacology | Nitroarginine - pharmacology | Aorta, Thoracic - cytology | Calcium Chloride - pharmacology | Animals | Saponins - isolation & purification | Triterpenes - isolation & purification | Vasodilator Agents - chemistry | Nitric Oxide Synthase - metabolism | Vasodilation - drug effects | In Vitro Techniques | Saponins - pharmacology | NG-Nitroarginine Methyl Ester, pharmacology | Triterpenes, pharmacology | Calcium, metabolism | Nitric Oxide Synthase, antagonists and inhibitors | Muscle, Smooth, Vascular, metabolism | Vasodilator Agents, chemistry | Quinoxalines, pharmacology | Aorta, Thoracic, drug effects | Triterpenes, chemistry | Vasodilator Agents, pharmacology | Saponins, chemistry | Intracellular Fluid, drug effects | Nitric Oxide Synthase, metabolism | Aorta, Thoracic, cytology | Potassium Chloride, pharmacology | Aorta, Thoracic, physiology | Calcium Chloride, pharmacology | Vasoconstrictor Agents, pharmacology | Muscle, Smooth, Vascular, drug effects | Nitroarginine, pharmacology | Saponins, pharmacology | Vasodilation, drug effects | Triterpenes, isolation and purification | Cyclic GMP, biosynthesis | Vasodilator Agents, isolation and purification | Acetylcholine, pharmacology | Oxadiazoles, pharmacology | Muscle, Smooth, Vascular, cytology | Phenylephrine, pharmacology | Saponins, isolation and purification | Endothelium, Vascular, physiology | Indomethacin, pharmacology | Intracellular Fluid, metabolism
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 09/2004, Volume 24, Issue 36, pp. 7821 - 7828
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 1440-1681, 02/2008, Volume 35, Issue 2, pp. 192 - 200
SUMMARY • The present study evaluated the effect of diabetes, hypercholesterolaemia and their combination on the contribution of nitric oxide (NO) and... 
endothelium-derived hyperpolarising factor | diabetes | endothelium-dependent relaxation | hypercholesterolaemia | superoxide anion | endothelium‐derived hyperpolarising factor | endothelium‐dependent relaxation | Superoxide anion | Diabetes | Hypercholesterolaemia | Endothelium-dependent relaxation | Endothelium-derived hyperpolarising factor | PHYSIOLOGY | NITRO-L-ARGININE | ACETYLCHOLINE | MELLITUS | NAD(P)H OXIDASE | ARTERIES | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | CHANNELS | DYSFUNCTION | EDHF | Body Weight | Oxidative Stress | Cholesterol - blood | Diabetes Mellitus, Type 1 - metabolism | Nitric Oxide Synthase - antagonists & inhibitors | Male | Guanylate Cyclase - antagonists & inhibitors | Nitroprusside - pharmacology | Apamin - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Charybdotoxin - pharmacology | Oxadiazoles - pharmacology | Potassium Channels, Calcium-Activated - metabolism | Superoxides - metabolism | Aorta, Thoracic - drug effects | Biological Factors - metabolism | Diabetes Mellitus, Experimental - metabolism | Potassium Channel Blockers - pharmacology | Diabetes Mellitus, Experimental - physiopathology | Disease Models, Animal | Vasodilator Agents - pharmacology | Acetylcholine - pharmacology | Diabetes Mellitus, Type 1 - physiopathology | Enzyme Inhibitors - pharmacology | Aorta, Thoracic - metabolism | Rats | Guanylate Cyclase - metabolism | Soluble Guanylyl Cyclase | Aorta, Thoracic - physiopathology | Rats, Sprague-Dawley | Indomethacin - pharmacology | Cyclooxygenase Inhibitors - pharmacology | Nitroarginine - pharmacology | Aorta, Thoracic - enzymology | Animals | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Hypercholesterolemia - physiopathology | Nitric Oxide Synthase - metabolism | Potassium Channels, Calcium-Activated - antagonists & inhibitors | Vasodilation - drug effects | Blood Glucose - metabolism | Nitric Oxide - metabolism | Hypercholesterolemia - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism | Charybdotoxin, pharmacology | Diabetes Mellitus, Type 1, physiopathology | Nitric Oxide Synthase, antagonists and inhibitors | Aorta, Thoracic, physiopathology | Potassium Channels, Calcium-Activated, antagonists and inhibitors | Hypercholesterolemia, metabolism | Quinoxalines, pharmacology | Enzyme Inhibitors, pharmacology | Aorta, Thoracic, drug effects | Aorta, Thoracic, metabolism | Receptors, Cytoplasmic and Nuclear, antagonists and inhibitors | Vasodilator Agents, pharmacology | Vasodilation | Nitric Oxide Synthase, metabolism | Cyclooxygenase Inhibitors, pharmacology | Apamin, pharmacology | Nitroarginine, pharmacology | Potassium Channel Blockers, pharmacology | Vasodilation, drug effects | Cholesterol, blood | Receptors, Cytoplasmic and Nuclear, metabolism | Biological Factors, metabolism | Diabetes Mellitus, Experimental, physiopathology | Nitric Oxide, metabolism | Acetylcholine, pharmacology | Diabetes Mellitus, Experimental, metabolism | Nitroprusside, pharmacology | Oxadiazoles, pharmacology | Blood Glucose, metabolism | Potassium Channels, Calcium-Activated, metabolism | Aorta, Thoracic, enzymology | Hypercholesterolemia, physiopathology | Diabetes Mellitus, Type 1, metabolism | Guanylate Cyclase, antagonists and inhibitors | Guanylate Cyclase, metabolism | Superoxides, metabolism | Indomethacin, pharmacology | Superoxide | Hypercholesterolemia | Endothelium-derived relaxing factors | Type 1 diabetes | Endothelium
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 09/2012, Volume 32, Issue 38, pp. 13100 - 13110
Astrocytes contribute to many neuronal functions, including synaptogenesis, but their role in the development of synaptic plasticity remains unclear.... 
NEUROPATHIC PAIN | PYRAMIDAL CELLS | PROTEIN-KINASE | NECROSIS-FACTOR-ALPHA | SILENT SYNAPSES | ANTIEPILEPTIC DRUGS | GABAPENTIN | DIFFERENTIAL REGULATION | NEUROSCIENCES | CALCIUM-CHANNEL | GLIAL TNF-ALPHA | Electric Stimulation | Coculture Techniques | Culture Media, Conditioned - chemistry | Neuronal Plasticity - drug effects | Culture Media, Conditioned - pharmacology | Male | Excitatory Postsynaptic Potentials - drug effects | N-Methylaspartate - pharmacology | Thrombospondins - pharmacology | Quinoxalines - pharmacology | CREB-Binding Protein - metabolism | Cyclic AMP - analogs & derivatives | Potassium Chloride - pharmacology | Statistics, Nonparametric | Female | Phosphorylation - drug effects | Hippocampus - growth & development | Organ Culture Techniques | Receptors, AMPA - metabolism | Animals, Newborn | Synapses - drug effects | Presynaptic Terminals - drug effects | Vesicular Glutamate Transport Protein 1 - metabolism | Valine - analogs & derivatives | Rats | gamma-Aminobutyric Acid - pharmacology | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Adenosine - pharmacology | Biophysics | Thionucleotides - pharmacology | Hippocampus - cytology | Rats, Sprague-Dawley | Cyclic AMP - pharmacology | Nerve Tissue Proteins - metabolism | Astrocytes - physiology | Patch-Clamp Techniques | Animals | Cyclohexanecarboxylic Acids - pharmacology | Adenosine - analogs & derivatives | Dynamin I - metabolism | Protein Kinase Inhibitors - pharmacology | Valine - pharmacology | Amines - pharmacology | Thrombospondins - metabolism
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2011, Volume 31, Issue 14, pp. 5205 - 5212
Alcohol addiction (alcoholism) is one of the most prevalent substance abuse disorders worldwide. Addiction is thought to arise, in part, from a maladaptive... 
CHRONIC INTERMITTENT ETHANOL | CORTICOTROPIN-RELEASING-FACTOR | INOSITOL 1,4,5-TRISPHOSPHATE | C57BL/6J MICE | PROTEIN-KINASE | GABAERGIC SYNAPSES | CA2+ CHANNELS | MIDBRAIN DOPAMINE NEURONS | LONG-TERM POTENTIATION | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | Peptide Hormones - pharmacology | Electric Stimulation | Receptors, N-Methyl-D-Aspartate - metabolism | Conditioning, Operant - physiology | Neuronal Plasticity - drug effects | Inositol 1,4,5-Trisphosphate - pharmacology | Male | Ventral Tegmental Area - cytology | Central Nervous System Depressants - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Drug Interactions | Conditioning, Operant - drug effects | Long-Term Potentiation - drug effects | Long-Term Potentiation - physiology | Neurons - drug effects | Ventral Tegmental Area - drug effects | Dopamine Uptake Inhibitors - pharmacology | Drug Administration Schedule | Amphibian Proteins - pharmacology | Colforsin - pharmacology | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Biophysics | Corticotropin-Releasing Hormone - pharmacology | Cocaine - pharmacology | Methoxyhydroxyphenylglycol - analogs & derivatives | Methoxyhydroxyphenylglycol - pharmacology | Ethanol - pharmacology | Animals | Analysis of Variance | Dopamine Antagonists - pharmacology | Mice | In Vitro Techniques | Salicylamides - pharmacology
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2011, Volume 31, Issue 14, pp. 5235 - 5243
R-type calcium channels in postsynaptic spines signal through functional calcium microdomains to regulate a calcium/calmodulin-sensitive potassium channel that... 
DENDRITIC SPINES | TRANSMITTER RELEASE | MUTANT MICE | I ADENYLYL-CYCLASE | CA2+ CHANNELS | EXCITATORY SYNAPSES | CEREBELLAR SYNAPSE | MAMMALIAN BRAIN SLICE | SYNAPTIC PLASTICITY | NEUROSCIENCES | GRANULE CELL | Neural Pathways - drug effects | Calcium - metabolism | Membrane Microdomains - metabolism | Adenosine A1 Receptor Antagonists - pharmacology | Spider Venoms - pharmacology | Xanthines - pharmacology | Neural Pathways - physiology | Patch-Clamp Techniques - methods | Purkinje Cells - physiology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | omega-Conotoxin GVIA - pharmacology | Long-Term Potentiation - drug effects | Piperidines - pharmacology | Purkinje Cells - cytology | omega-Agatoxin IVA - pharmacology | Long-Term Potentiation - physiology | Tetrodotoxin - pharmacology | Nickel - pharmacology | Electric Stimulation - methods | Pyrazoles - pharmacology | Animals, Newborn | Presynaptic Terminals - drug effects | Rats | Sodium Channel Blockers - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Presynaptic Terminals - physiology | Calcium Channel Blockers - pharmacology | Rats, Sprague-Dawley | GABA Antagonists - pharmacology | Animals | Analysis of Variance | Calcium Signaling - drug effects | Membrane Microdomains - drug effects | Phosphinic Acids - pharmacology | Cerebellum - cytology | In Vitro Techniques | Propanolamines - pharmacology | Calcium Channels, R-Type - metabolism
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2011, Volume 31, Issue 6, pp. 2280 - 2291
In the mammalian retina, excitatory and inhibitory circuitries enable retinal ganglion cells (RGCs) to signal the occurrence of visual features to higher brain... 
ELECTRICAL SYNAPSES | AII AMACRINE CELLS | GLUTAMATE RECEPTORS | GAP-JUNCTIONS | HORIZONTAL CELLS | GANGLION-CELLS | ECTOPIC EXPRESSION | RESTORES VISUAL RESPONSES | RETINITIS-PIGMENTOSA | MORPHOMETRIC-ANALYSIS | NEUROSCIENCES | Meclofenamic Acid - pharmacology | Age Factors | 2-Amino-5-phosphonovalerate - pharmacology | Male | Gap Junctions - genetics | Statistics as Topic | Nerve Net - drug effects | Pyridazines - pharmacology | Mice, Neurologic Mutants | Quinoxalines - pharmacology | Evoked Potentials, Visual - physiology | Light | Tetrodotoxin - pharmacology | Nerve Net - physiopathology | Retinal Rod Photoreceptor Cells - drug effects | Action Potentials - drug effects | Disease Models, Animal | Glutamic Acid - pharmacology | Retinal Degeneration - genetics | Mice, Inbred C57BL | Periodicity | gamma-Aminobutyric Acid - pharmacology | Sodium Channel Blockers - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Mice, Inbred C3H | Cyclooxygenase Inhibitors - pharmacology | GABA Antagonists - pharmacology | Action Potentials - physiology | Carbenoxolone - pharmacology | Animals | Evoked Potentials, Visual - drug effects | Glycine - pharmacology | Retinal Rod Photoreceptor Cells - physiology | 2-Amino-5-phosphonovalerate - analogs & derivatives | Mice | Gap Junctions - drug effects | In Vitro Techniques | Retinal Degeneration - pathology | Neural Inhibition - drug effects
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2008, Volume 28, Issue 14, pp. 3769 - 3780
Journal Article
Neuron (Cambridge, Mass.), ISSN 0896-6273, 2009, Volume 62, Issue 1, pp. 53 - 71
The molecular mechanisms controlling the termination of cortical interneuron migration are unknown. Here, we demonstrate that, prior to synaptogenesis,... 
CELLBIO | DEVBIO | MOLNEURO | NEURONAL MIGRATION | CHLORIDE HOMEOSTASIS | DOWN-REGULATION | GABAERGIC INTERNEURONS | GENE-EXPRESSION | CL-COTRANSPORTER KCC2 | TANGENTIAL MIGRATION | DEVELOPING CEREBRAL-CORTEX | NEUROSCIENCES | MEDIAL GANGLIONIC EMINENCE | INTERMEDIATE ZONE | Interneurons - physiology | Muscimol - pharmacology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Sequence Deletion | Age Factors | Calcium - metabolism | Embryo, Mammalian | Microtubule-Associated Proteins - metabolism | Green Fluorescent Proteins - genetics | Cerebral Cortex - cytology | Cell Movement - physiology | Quinoxalines - pharmacology | omega-Conotoxin GVIA - pharmacology | Symporters - antagonists & inhibitors | Female | Organ Culture Techniques | Bicuculline - analogs & derivatives | Animals, Newborn | Membrane Potentials - drug effects | Nifedipine - pharmacology | Glutamic Acid - pharmacology | RNA, Small Interfering - pharmacology | Valine - analogs & derivatives | gamma-Aminobutyric Acid - pharmacology | Calcium Channels, L-Type - physiology | Mice, Transgenic | Bicuculline - pharmacology | Calcium Channel Blockers - pharmacology | Electroporation - methods | Membrane Potentials - physiology | Nerve Tissue Proteins - genetics | Homeodomain Proteins - genetics | Symporters - metabolism | Gene Expression Regulation - drug effects | Pregnancy | Cell Movement - drug effects | GABA Agents - pharmacology | Animals | Models, Biological | Symporters - genetics | LIM-Homeodomain Proteins | Mice | Mice, Inbred BALB C | Transcription Factors | Valine - pharmacology | GABA | Methyl aspartate | Calcium channels | Neurosciences | Glutamate | Membrane potentials | Brain | Motility | Microscopy | Neurons | Rodents | Migration | Colleges & universities | Index Medicus
Journal Article
Annual review of pharmacology and toxicology, ISSN 1545-4304, 2009, Volume 49, Issue 1, pp. 57 - 71
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 1373 - 14
Using an ORF kinome screen in MCF-7 cells treated with the CDK4/6 inhibitor ribociclib plus fulvestrant, we identified FGFR1 as a mechanism of drug resistance.... 
Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Cyclin D1 - metabolism | Receptors, Estrogen - metabolism | Circulating Tumor DNA - genetics | Humans | Purines - administration & dosage | Fulvestrant - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Quinolines - pharmacology | Breast Neoplasms - metabolism | Quinoxalines - pharmacology | MCF-7 Cells | Fulvestrant - administration & dosage | Female | Receptor, Fibroblast Growth Factor, Type 2 - antagonists & inhibitors | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyrazoles - pharmacology | Aminopyridines - administration & dosage | Antineoplastic Agents, Hormonal - pharmacology | Signal Transduction | Purines - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Proportional Hazards Models | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Naphthalenes - pharmacology | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aminopyridines - pharmacology | Progression-Free Survival | High-Throughput Nucleotide Sequencing | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Mutation | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Drug Resistance, Neoplasm - drug effects | Tyrosine | Xenotransplantation | Clinical trials | Antagonists | Breast cancer | Drug resistance | Patients | Cyclin-dependent kinase 4 | Fulvestrant | Gene sequencing | Amplification | Next-generation sequencing | Inhibitors | Xenografts | Open reading frames | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | DNA sequencing | Cancer | Fibroblast growth factor receptors
Journal Article